Beyond the end exceptionlism: Integrating HIV testing into routine medical care and HIV prevention

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 4, 2007, Pages 581-589

  Smith, Rachel ^a   Zetola, Nicola M ^b   Klausner, Jeffrey D ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Acute HIV infection; HIV exceptionalism; HIV testing; Routine HIV screening

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH EDUCATION; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; MASS SCREENING; MEDICAL CARE; PRACTICE GUIDELINE; PUBLIC HEALTH; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UNITED STATES; VERTICAL TRANSMISSION; VIRUS DETECTION; DISEASE TRANSMISSION; REVIEW;

DIAGNOSTIC TESTS, ROUTINE; HIV INFECTIONS; HUMANS; IMMUNOENZYME TECHNIQUES; PRACTICE GUIDELINES; PUBLIC HEALTH;

EID: 85047698520     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.4.581     Document Type: Article

References (63)

1. CDC. Pneumocystis pneumonia - Los Angeles. Morb. Mortal. Wkly Rep. 30(21), 250-252 (1981).
2. CDC. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. Morb. Mortal. Wkly Rep. 52(15), 329-332 (2003).
3. CDC. The global HIV/AIDS pandemic, 2006. Morb. Mortal. Wkly Rep. 55(31), 841-844 (2006).
4. CDC. Twenty five years of HIV/AIDS - United States 1981-2006. Morb. Mortal. Wkly Rep. 55(21), 585-589 (2006).
5. CDC. U.S. HIV and AIDS cases reported through December 2001. HIV/AIDS Surveillance Report 13(2), 1-44 (2001).
6. CDC. Trends in HIV/AIDS diagnoses - 33 states, 2001-2004. Morb. Mortal. Wkly Rep. 54(45), 1149-1153 (2005).
7. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003. Presented at: The National HIV Prevention Conference. Atlanta, GA, USA June 2005 (Abstract T1-B1101).
8. Marks G. Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J. Acquir. Immune Defic. Syndr. 39(4), 446-453 (2005).
9. CDC. Late versus early testing of HIV-16 sites, United States, 2000-2003. Morb. Mortal. Wkly Rep. 52(25), 581-586 (2003).
10. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 16(14), 1945-1951 (2002).
11. Schwarcz S, Hsu L, Dilly JW, Loeb L, Nelson K, Boyd S. Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. J. Acquir. Immune Defic. Syndr. 43(4), 491-494 (2006).
12. Chesney MA, Smith AW. Critical delays in HIV testing and care: the potential role of stigma. Am. Behav. Sci. 42(7), 1158-1170 (1999).
13. Bayer R, Fairchild AL. Changing the paradigm for HIV testing - the end of exceptionalism. N. Engl. J. Med. 355(7), 647-649 (2006).
14. CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. MMWR Recomm. Rep. 55 (RR14), 1-17 (2006).
15. Zetola N, Klausner JD. HIV testing: an update. MLO Med. Labs Obs. 38(9), 58, 60-63 (2006).
16. Wright AA, Katz IT. Home testing for HIV. N. Engl. J. Med. 354(5), 437-440 (2006).
17. Delaney KP, Branson BM, Uniyal A et al. Performance of an oral fluid HIV-1/2 test: experience from our four CDC studies. AIDS20(12), 1655-1660 (2006).
18. Speilberg F, Branson B, Goldbaum, GM et al. Choosing HIV counseling and testing strategies for outreach settings. J. Acquir. Immune Defic. Syndr. 38(3), 348-355 (2005).
19. Sherlock M, Zetola NM, Klausner JD. Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States. Sex Transm. Dis. 34(5), 314-316 (2007).
20. Pilcher CD, Fiscus SA, Nguyen TQ et al. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 352(18), 1873-1883 (2005).
21. Yilmaz G. Diagnosis of HIV infection and laboratory monitoring of its therapy. J. Clin. Vir. 21(3), 187-196 (2001).
22. Koopman JS, Jacquez JA, Welch GW et al. The role of early HIV infection in the spread of HIV through populations. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14(3), 249-258 (1997).
23. Leynaert B, Downs AM, de Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European study group on heterosexual transmission of HIV. Am. J. Epidemiol. 148(1), 88-96 (1998).
24. Nicolau JE, Benard G, Fonseca LA et al. HIV transmission to stable sexual partners of HIV infected Brazilian hemophiliacs. Sao Paulo Med. J. 114(3), 1186-1189 (1996).
25. Wawer MJ, Gray RH, Sewankambo NK et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J. Infect. Dis. 191(9), 1403-1409 (2005).
26. Stramer SL, Glynn SA, Kleinman SH et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N. Engl. J. Med. 351(8), 760-768 (2004).
27. Klausner JD, Grant RM, Kent CK. Detection of acute HIV infections. N. Engl. J. Med. 353(6), 631-633 (2005).
28. Priddy FH, Pilcher CD, Moore RH et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J. Aquir. Immune Defic. Syndr. 44(2), 196-202 (2007).
29. Daar ES, Little S, Pitt J et al. Diagnosis of primary HIV-1 infection. Los Angeles County primary HIV infection recruitment network. Ann. Intern. Med. 134(1), 25-29 (2001).
30. Weintrob AC, Giner J, Menezes P et al. Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Ann. Intern. Med. 163(17), 2097-2100 (2003).
31. Patel P, Klausner JD, Bacon OM et al. Detection of acute HIV in high risk patients in California. J. Acquir. Immune Defic. Syndr. 42(1), 75-79 (2006).
32. Pincus JM, Crosby SS, Losina E, King ER, LaBelle C, Freedberg KA. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin. Infect. Dis. 37(12), 1699-1704 (2003).
33. Rosenberg ES, Caliendo AM, Walker BD. Acute HIV infection among patients tested for mononucleosis. N. Engl. J. Med. 340(12), 969 (1999).
34. Klausner J, Philip S, Ahrens K et al. Combined rapid and RNA testing improves case detection and potential prevention in a public STD clinic, San Francisco 2004-2006. Presented at: 14th Conference on Retrovirus and Opportunistic Infections. Los Angeles, CA, USA, 25-28 February 2007.
35. Fiscus SA, Pilcher CD, Miller WC et al. Rapid, real time detection of acute HIV in patients in Africa. J. Infect. Dis. 195(3), 416-424 (2007).
36. Hodge JG. Advancing HIV prevention initiative: a limited legal analysis of state HIV statutes: initial assessment for the Centers for Disease Control and Prevention, as of September 2004: the center for law and the public's health at Georgetown and John's Hopkins Universities. AHP Report. (2004).
37. Chen Z, Branson B, Ballenger A, Peterman TA. Risk assessment to improve targeting of HIV counseling and testing services for STD clinic patients. Sex. Transm. Dis. 25(10), 539-543 (1999).
38. Klein D, Hurley LB, Merrill D, Quesenberry CP Jr: Consortium for HIV/ AIDS Interregional Research. Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J. Acquir. Immune Defic. Syndr. 32(2), 143-152 (2003).
39. Walensky RP, Weinstein MC, Kimmel AD et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am. J. Med. 118(3), 292-300 (2005).
40. Zetola NM, Klausner JD, Haller B, Nassos F Katz MH. Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA 297(10), 1061-1062 (2007).
41. Gostin LO, Ward JW, Baker AC. National HIV case reporting for the United States: a defining moment in the history of the epidemic. N. Engl. J. Med. 337(16), 1162-1167 (1997).
42. Wilson JM, Jungner G. Principles and Practice of Screening for Disease. WHO, Geneva, Switzerland (1968).
43. Paltiel AD, Weinstein MC, Kimmel AD et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N. Engl. J. Med. 352(6), 586-595 (2005).
44. Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implication for secondary HIV transmission during and after HIV seroconversion. AIDS 16(11), 1529-1535 (2002).
45. Brewer TH, Zhao W, Metsch LR, Coltes A, Zenilman J. High risk behavior in women who use crack: knowledge of HIV serostatus and risk behavior. Ann. Epidemiol. 17(7), 533-539 (2007).
46. Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH. Assessing missed opportunities for HIV testing in a medical setting. J. Gen. Intern. Med. 19(4), 349-356 (2004).
47. Chou R, Huffman LH, Fu R, Smits AK, Korthuis PT; US Preventative Services Task Force. Screening for HIV: a review of the evidence for the US Preventative Service Task Force. Ann. Intern. Med. 143(1), 55-73 (2005).
48. [No author listed]. Nationwide effort targets earlier diagnosis and treatment for HIV. Dis. Manag. Advis. 7(11), 170-172, 161 (2001).
49. Smith DE, Walker BD, Cooper DA, Rosenberg FS, Kaldor JM. Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS 18(5), 709-718 (2004).
50. Chun TW, Justement JS, Moir S et al. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J. Infect. Dis. 195(12), 1762-1764 (2007).
51. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin. Infect. Dis. 38(10), 1447-1453 (2004).
52. Zetola NM, Pilcher CD. Diagnosis and management of acute HIV infection. Infect. Dis. Clin. North Am. 21(1), 19-48 (2007).
53. Conner EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl. J. Med. 331(18), 1173-1180 (1994).
54. Barbacci MB, Dalabetta CA, Repke JT et al. Humman immunodeficiency virus infection in women attending an inner-city prenatal clinic: ineffectiveness of targeted screening. Sex. Transm. Dis. 17(3), 122-126 (1990).
55. Lindsay MK, Adefris W, Peterson HB, Williams H, Johnson J, Klein L. Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population. Obster. Gynecol. 78(4), 678-690 (1991).
56. CDC. Achievements in public health: Reduction in perinatal transmission of HIV infection - United States 1985-2005. Morb. Mortal. Wkly Rep. 55(21), 592-597 (2006).
57. Dodd RY, Notari EP, Strainer SL. Current prevalence and incidence of infectious disease markets and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42(8), 975-979 (2002).
58. Wynia MK. Routine screening: informed consent, stigma, and the waning of HIV exceptionalism. Am. J. Bioeth. 6(4), 5-8 (2006).
59. [No author listed]. California, Maine laws out of sync with CDC over routine HIV testing. AIDS Policy Law 22(2), 1, 4 (2007).
60. [No author listed]. Have tents, will travel in San Francisco. Testing facilities travel to clients. AIDS Alert 20(2), 21-22 (2005).
61. Butcher JB, Thomas KM, Guzman D, Riley E, Dela Cruz N, Bangsberg D. Community based rapid testing in homeless and marginally housed adults in San Francisco. HIV Med. 8(1), 28-31 (2007).
62. [No author listed]. Massachusetts project cuts a wide swath of care. Nontraditional testing sites is main focus. AIDS Alert 20(2), 18-19 (2005).
63. Levine DK, Scott KC, Klausner JD. Online syphilis testing - confidential and convenient. Sex. Transm. Dis. 32(2), 139-141 (2005).